BlockBeats 消息，9 月 16 日，港股创新药企药捷安康股价盘中一度飙升超 60%，市值接近 2700 亿港元。自 6 月 23 日上市以来，不到三个月股价暴涨超 50 倍，被市场称为“港股版 Meme 币”，在资本狂热下成为新的炒作热点。
药捷安康的暴涨导火索，是核心产品替恩戈替尼的一项临床试验获批临床默示许可。这款药被誉为“全球首个进入注册临床阶段的 FGFR 抑制剂”，市场想象空间巨大。然而公司尚无商业化产品，三年累计亏损 8.7 亿元，2025 年上半年仍无营收。其“千亿市值”更像是加密市场中 Meme 币的故事驱动，缺乏基本面支撑。
BiyaPay 分析师指出，药捷安康的走势与币圈熟悉的 Meme 币颇为相似：流通盘小、消息刺激强、情绪带动资金涌入。在资金推动下，股价短期疯狂拉升，但能否长期站稳仍是未知数。
对于加密投资者而言，这类港股“新 Meme 币”式行情正成为新的投机战场。通过 BiyaPay，用户不仅能零手续费交易 BTC、ETH 等数字货币，还能一站式参与美股与港股投资，把握类似药捷安康这样的“妖股”机会，实现跨市场灵活配置。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.